Buy Deus Medical FEMAMED 2.5 Letrozole Online

Deus Medical FEMAMED 2.5 contains letrozole 2.5 mg, an active pharmaceutical ingredient belonging to the class of medicines known as non-steroidal aromatase inhibitors. Letrozole works by inhibiting the aromatase enzyme, thereby reducing the production of estrogen in the body. It is an established prescription medicine used in specific hormone-dependent breast-cancer treatment settings, particularly in postmenopausal women.

If you are researching Buy Deus Medical FEMAMED 2.5 Letrozole Online, it is important to understand the product, its active ingredient, approved medical uses, dosage information and safety considerations before making a purchase or using it. FEMAMED 2.5 should be used under the supervision of an appropriately qualified healthcare professional.

What Is Deus Medical FEMAMED 2.5?

FEMAMED 2.5 is a letrozole product manufactured by Deus Medical. The manufacturer’s product information identifies the active ingredient as letrozole and lists the strength as 2.5 mg per tablet. Letrozole is classified as a non-steroidal, Type II aromatase inhibitor.

Aromatase is an enzyme involved in estrogen production. By inhibiting aromatase, letrozole reduces estrogen biosynthesis. This mechanism is clinically relevant because the growth of some breast cancers depends on estrogen signaling.

Key Features of FEMAMED 2.5

• Active ingredient: Letrozole
• Strength: 2.5 mg per tablet
• Drug class: Aromatase inhibitor
• Product: Deus Medical FEMAMED 2.5
• Administration: Oral tablet
• Chemical formula of letrozole: C17H11N5
• Molecular weight: approximately 285.3 g/mol
• Prescription medicine requiring appropriate medical supervision.

Ingredients and Composition

The primary active pharmaceutical ingredient in FEMAMED 2.5 is letrozole 2.5 mg. Deus Medical’s product information also states that the formulation contains excipients. The precise inactive ingredients can vary between manufacturers and formulations, so customers should check the packaging and official product documentation supplied with their specific medicine.

For comparison, approved 2.5 mg letrozole formulations may contain excipients such as lactose, microcrystalline cellulose, maize starch, sodium starch glycolate, magnesium stearate and coating materials. These ingredients should not automatically be assumed to be identical to those in every FEMAMED formulation.

Benefits and Medical Uses of Letrozole

The principal therapeutic effect of letrozole is suppression of estrogen production through aromatase inhibition. Approved letrozole products are used for several hormone-dependent breast-cancer indications, including adjuvant treatment of certain postmenopausal patients with hormone-receptor-positive early breast cancer and treatment of certain advanced or metastatic breast cancers.

The appropriate indication depends on an individual’s diagnosis, menopausal status, previous treatment and other clinical factors. Letrozole should therefore not be treated as a general-purpose hormone or performance-enhancing product.

Recommended Usage and Dosage

For approved breast-cancer indications, the standard recommended dose for many adult patients is 2.5 mg once daily, although the appropriate regimen depends on the patient’s clinical circumstances and the prescribing information applicable in their country.

Do not change the dose, frequency or duration of treatment without medical advice. A healthcare professional should determine whether letrozole is appropriate and how long treatment should continue.

Stacking and Combining Letrozole

Letrozole should not be casually “stacked” with other medicines, hormones or supplements. In particular, the manufacturer’s information warns about important interactions involving estrogen and tamoxifen, while official prescribing information highlights the need to consider other medicines being taken.

If you are taking other prescription medicines, over-the-counter products, vitamins or supplements, provide the complete list to your doctor or pharmacist before using letrozole. A healthcare professional can determine whether combination treatment is medically appropriate.

Safety and Precautions

Letrozole can cause adverse effects and requires appropriate medical monitoring. Reported effects include hot flashes, sweating, joint or bone pain, fatigue, dizziness, nausea and changes in cholesterol levels. Letrozole can also reduce bone mineral density, making bone health an important consideration during treatment.

Letrozole is contraindicated during pregnancy because it can cause fetal harm. Women who could become pregnant should discuss pregnancy testing and effective contraception with their healthcare professional. Breast-feeding is also contraindicated in official product information.

Patients with significant liver or kidney impairment may require additional medical assessment. People with a history or increased risk of osteoporosis may also require bone-density assessment and monitoring.

Why Product Verification Matters

When researching Buy Deus Medical FEMAMED 2.5 Letrozole Online, customers should verify the product source, packaging, batch information, expiry date and authenticity before using any medicine. Deus Medical itself provides product information for FEMAMED 2.5 and identifies authorized-reseller arrangements.

A legitimate pharmaceutical purchase should provide appropriate product information and should not rely on exaggerated claims such as guaranteed results, instant hormone control or suitability for everyone.

Frequently Asked Questions

What is FEMAMED 2.5?

FEMAMED 2.5 is a Deus Medical product containing 2.5 mg of letrozole, a non-steroidal aromatase inhibitor.

What is letrozole 2.5 mg used for?

Letrozole is used for specific hormone-dependent breast-cancer indications, particularly in postmenopausal patients, according to approved prescribing information.

How does letrozole work?

Letrozole inhibits aromatase, an enzyme involved in estrogen biosynthesis. Reduced estrogen production can reduce estrogen-mediated stimulation of certain hormone-dependent breast cancers.

Is FEMAMED 2.5 a prescription medicine?

Letrozole is a prescription medicine in many jurisdictions. The legal status and dispensing requirements depend on the country where the medicine is supplied.

What is the usual letrozole dose?

For several approved breast-cancer indications, the recommended adult dose is 2.5 mg once daily. The prescribing clinician should determine the appropriate treatment for an individual patient.

Can letrozole be taken with tamoxifen?

Letrozole and tamoxifen have clinically important interactions and should not be combined or switched between without direction from the treating healthcare professional.

Can letrozole be used during pregnancy?

No. Official prescribing information identifies pregnancy as a contraindication because letrozole can cause fetal harm.

What are common side effects of letrozole?

Commonly reported effects include hot flashes, joint or musculoskeletal symptoms, sweating, fatigue, dizziness and headache. Changes in cholesterol and bone mineral density can also occur.

Does letrozole affect bone health?

Yes. Because letrozole substantially reduces estrogen levels, bone mineral density can decrease. Appropriate patients may require bone-health assessment and monitoring during treatment.

Can I use letrozole with supplements?

Tell your doctor or pharmacist about all supplements and medicines you use. Some products can interact with prescription medicines, and supplements should not be assumed to be safe simply because they are sold without a prescription.

Should I use FEMAMED 2.5 without medical supervision?

No. Letrozole is a potent prescription medicine. Appropriate use depends on the patient’s diagnosis, menopausal status, medical history, other medicines and monitoring requirements.